Abu Dhabi Investment Office (ADIO) has announced a strategic agreement with German biotechnology company Bayer aimed at establishing a framework to explore collaboration across health, life sciences, food security, philanthropy and innovation ecosystems.
A sharp rise in life-sciences mergers and acquisitions (M&A) are likely across the Middle East as Gulf governments intensify efforts to build a globally competitive biotech and health-technology manufacturing base, according to a new Grand View Research study.
